These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 21412073)

  • 1. Different roles of S100P overexpression in intrahepatic cholangiocarcinoma: carcinogenesis of perihilar type and aggressive behavior of peripheral type.
    Aishima S; Fujita N; Mano Y; Kubo Y; Tanaka Y; Taketomi A; Shirabe K; Maehara Y; Oda Y
    Am J Surg Pathol; 2011 Apr; 35(4):590-8. PubMed ID: 21412073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S100P immunostaining identifies a subset of peripheral-type intrahepatic cholangiocarcinomas with morphological and molecular features similar to those of perihilar and extrahepatic cholangiocarcinomas.
    Tsai JH; Huang WC; Kuo KT; Yuan RH; Chen YL; Jeng YM
    Histopathology; 2012 Dec; 61(6):1106-16. PubMed ID: 22882148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proposal of progression model for intrahepatic cholangiocarcinoma: clinicopathologic differences between hilar type and peripheral type.
    Aishima S; Kuroda Y; Nishihara Y; Iguchi T; Taguchi K; Taketomi A; Maehara Y; Tsuneyoshi M
    Am J Surg Pathol; 2007 Jul; 31(7):1059-67. PubMed ID: 17592273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical analysis of the progression of flat and papillary preneoplastic lesions in intrahepatic cholangiocarcinogenesis in hepatolithiasis.
    Itatsu K; Zen Y; Ohira S; Ishikawa A; Sato Y; Harada K; Ikeda H; Sasaki M; Nimura Y; Nakanuma Y
    Liver Int; 2007 Nov; 27(9):1174-84. PubMed ID: 17919228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different expression of glucose transporters in the progression of intrahepatic cholangiocarcinoma.
    Kubo Y; Aishima S; Tanaka Y; Shindo K; Mizuuchi Y; Abe K; Shirabe K; Maehara Y; Honda H; Oda Y
    Hum Pathol; 2014 Aug; 45(8):1610-7. PubMed ID: 24824030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemically detected expression of p27(Kip1) and Skp2 predicts survival in patients with intrahepatic cholangiocarcinomas.
    Hashimoto N; Yachida S; Okano K; Wakabayashi H; Imaida K; Kurokohchi K; Masaki T; Kinoshita H; Tominaga M; Ajiki T; Ku Y; Okabayashi T; Hanazaki K; Hiroi M; Izumi S; Mano S; Okada S; Karasawa Y; Maeba T; Suzuki Y
    Ann Surg Oncol; 2009 Feb; 16(2):395-403. PubMed ID: 19034576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of MAGE-A3 in intrahepatic cholangiocarcinoma and its precursor lesions.
    Tsuneyama K; Sasaki M; Shimonishi T; Nakanuma Y
    Pathol Int; 2004 Mar; 54(3):181-6. PubMed ID: 14989741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased intratumoral arteries reflect portal tract destruction and aggressive characteristics in intrahepatic cholangiocarcinoma.
    Aishima S; Iguchi T; Nishihara Y; Fujita N; Taguchi K; Taketomi A; Maehara Y; Tsuneyoshi M
    Histopathology; 2009 Mar; 54(4):452-61. PubMed ID: 19309397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma.
    Su MC; Hsu C; Kao HL; Jeng YM
    Cancer Lett; 2006 Apr; 235(1):34-9. PubMed ID: 16125303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different expression patterns of mucin core proteins and cytokeratins during intrahepatic cholangiocarcinogenesis from biliary intraepithelial neoplasia and intraductal papillary neoplasm of the bile duct--an immunohistochemical study of 110 cases of hepatolithiasis.
    Zen Y; Sasaki M; Fujii T; Chen TC; Chen MF; Yeh TS; Jan YY; Huang SF; Nimura Y; Nakanuma Y
    J Hepatol; 2006 Feb; 44(2):350-8. PubMed ID: 16360234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression.
    Aishima S; Kuroda Y; Nishihara Y; Taguchi K; Iguchi T; Taketomi A; Maehara Y; Tsuneyoshi M
    Hum Pathol; 2007 Dec; 38(12):1819-25. PubMed ID: 17854859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tenascin expression at the invasive front is associated with poor prognosis in intrahepatic cholangiocarcinoma.
    Aishima S; Taguchi K; Terashi T; Matsuura S; Shimada M; Tsuneyoshi M
    Mod Pathol; 2003 Oct; 16(10):1019-27. PubMed ID: 14559985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma-mass forming type.
    Shibahara H; Tamada S; Higashi M; Goto M; Batra SK; Hollingsworth MA; Imai K; Yonezawa S
    Hepatology; 2004 Jan; 39(1):220-9. PubMed ID: 14752841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different roles of inducible nitric oxide synthase and cyclooxygenase-2 in carcinogenesis and metastasis of intrahepatic cholangiocarcinoma.
    Aishima S; Mano Y; Tanaka Y; Kubo Y; Shirabe K; Maehara Y; Oda Y
    Hum Pathol; 2013 Jun; 44(6):1031-7. PubMed ID: 23260331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inverse correlation of aberrant expression of fragile histidine triad (FHIT) protein with cyclin D1 protein and prognosis in Chinese patients with cholangiocarcinoma.
    Zhao P; Lu Y; Zhong M; Liu L; Li B
    Acta Oncol; 2008; 47(8):1557-63. PubMed ID: 18618300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of MUC1 and MUC2 mucin antigens in intrahepatic bile duct tumors: its relationship with a new morphological classification of cholangiocarcinoma.
    Higashi M; Yonezawa S; Ho JJ; Tanaka S; Irimura T; Kim YS; Sato E
    Hepatology; 1999 Dec; 30(6):1347-55. PubMed ID: 10573510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two distinct pathways of carcinogenesis in primary sclerosing cholangitis.
    Zen Y; Quaglia A; Heaton N; Rela M; Portmann B
    Histopathology; 2011 Dec; 59(6):1100-10. PubMed ID: 22175890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metallothionein overexpression and its prognostic relevance in intrahepatic cholangiocarcinoma and extrahepatic hilar cholangiocarcinoma (Klatskin tumors).
    Schmitz KJ; Lang H; Kaiser G; Wohlschlaeger J; Sotiropoulos GC; Baba HA; Jasani B; Schmid KW
    Hum Pathol; 2009 Dec; 40(12):1706-14. PubMed ID: 19683330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of HSP27 is associated with poor clinical outcome in intrahepatic cholangiocarcinoma.
    Romani AA; Crafa P; Desenzani S; Graiani G; Lagrasta C; Sianesi M; Soliani P; Borghetti AF
    BMC Cancer; 2007 Dec; 7():232. PubMed ID: 18154639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aggressive surgical resection for hilar-invasive and peripheral intrahepatic cholangiocarcinoma.
    Nakagohri T; Asano T; Kinoshita H; Kenmochi T; Urashima T; Miura F; Ochiai T
    World J Surg; 2003 Mar; 27(3):289-93. PubMed ID: 12607053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.